Immunization Adjuvants
Sigma Aldrich Fine Chemicals Biosciences Freunds Adjuvant, Incomplete liquid
Freunds Adjuvant, Incomplete liquid
Sigma Aldrich Fine Chemicals Biosciences Freunds Adjuvant, Complete cell suspension, MFCD00131105
Freunds Adjuvant, Complete cell suspension
Invivogen Monophosphoryl Lipid A from S. minnesota R595 - TLR4-based adjuvant
The TLR4 agonist, MPLA (monophosphoryl lipid A) is a derivative of lipid A from Salmonella minnesota R595 lipopolysaccharide (LPS or endotoxin). MPLA is considerably less toxic than LPS whilst maintaining immunostimulatory activity.
Invivogen ALUMINUM HYDROXIDE GEL 250ML
Alhydrogel adjuvant 2% is an aluminium hydroxide (referred to as alum) wet gel suspension. Alum acts primarily through the formation of a depot at the injection site, enabling enhanced antigen availability, activation of antigen presenting cells (APCs) and uptake by immune cells. It can also activate innate immunity pathways triggered by pattern recognition receptors (PRRs). The NLR pathway has been recently described as an important mechanism in alum adjuvancy. Alum has been shown to activate the NLRP3 inflammasome although its role in alum-induced antibody response is controversial. 21645-51-2.
Echelon Biosciences Research Labs SQUALENE PURIFIED 10 mg
Squalene is a naturally occurring triterpenoid synthesized from two molecules of farnesyl diphosphate (FPP) by squalene synthase. Echelons squalene has been further purified to remove oxidized byproducts. This item is non returnable
Invivogen INCOMP FREUNDS ADJUVANT 6X10ML
FA (Incomplete Freunds adjuvant) is one of the most commonly used adjuvants in research. It is prepared from non-metabolizable oils.IFA can be used to produce water-in-oil emulsions of antigens.IFA induces a predominantly Th2-biased response through the formation of a depot at the injection site and the stimulation of antibody producing plasma cells. INVIVOGEN mfg# VAC-IFA-60
Invivogen Imiquimod VacciGrade, 5 mg
The imidazoquinoline compound Imiquimod is a guanosine derivative and agonist for TLR7. This TLR7 agonist, originally developed as type I IFN inducers, is an effective adjuvant by activating dendritic cells (DCs) and B cells to induce cytokines optimal for Th1 cell immunity, and antibody production.
Chondrex Inc CFA, 2 MG/ML X 5 ML
Heat-killed M. tuberculosis H37 RA (non-viable) suspended in Incomplete Freund's Adjuvant at a concentration of 2 mg/ml. 5 mL.
Chondrex Inc CFA, 1 MG/ML X 5 ML
Heat-killed M. tuberculosis H37 RA (non-viable) suspended in Incomplete Freund's Adjuvant at a concentration of 1 mg/ml. 5 mL.
Chondrex Inc CFA, 10 MG/ML x 5 ML
Heat-killed M. tuberculosis H37 RA (non-viable) suspended in Incomplete Freund's Adjuvant at a concentration of 10 mg/ml. 5 mL.